期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新型抗肿瘤药物依曼替尼布 被引量：1

A novel antineoplastic agents: imatinib
下载PDF
导出
摘要 依曼替尼布是一种新型的 2 苯胺基嘧啶类酪氨酸激酶抑制药 ,用于α 干扰素治疗失败后的慢性髓样白血病 (CML)慢性期病人、加速期病人、急变期病人的治疗。 Imatinib is a novel tyrosine protein kinases inhibitor of the 2-phenylaminopyrimidine derivative. It is indicated for the treatment of patients with chronic myeloid leukemia (CML) in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy. The clinical studies shows that imatinib is very effective in hematologic response and major cytogenetic response in CML patients.
作者 梁爽 刘超美
机构地区 中国人民解放军第二军医大学药学院有机化学教研室
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2002年第9期567-569,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 依曼替尼布 抗肿瘤药 慢性髓样白血病 治疗 imatinib antineoplastic agents leukemia, myeloid, chronic
分类号 R979.1 [医药卫生—药品] R733.72 [医药卫生—肿瘤]
  • 相关文献

参考文献12

  • 1[1]CORTES JE, TALPAZ M, BERAN M, et al. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results[J]. Cancer, 1995, 75(2):464-470.
  • 2[2]CLARK SS, MCLAUGHIN J, TIMMONS M, et al. Expression of a distinctive Bcr-Abl oncogene in PH1-positive acute lymphocytic leukemia(ALL)[J]. Science, 1988, 239(4841):775-777.
  • 3[3]DALEY GQ, Van ETTEN RA, BALTIMOR D, et al. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome[J]. Science, 1990, 247(4944):824-830.
  • 4[4]MELO JV. The diversity of Bcr-Abl fusion proteins and their relationship to leukemia phenotype[J]. Blood, 1996, 88(7):2375-2384.
  • 5[5]PANE F, FRIGERI F, SINDONA M, et al. Neutrophilic-chronic myeloid leukemia: A distinct disease with a specific molecular marker (Bcr-Abl with C 3/A 2 junction)[J]. Blood, 1996, 88(7):2410-2414.
  • 6[6]KONOPKA JB, WATANABE SM, WITTE ON. An alteration of the human c-abl protein in K 562 leukemia cells unmasks associated tyrosine kinase activity[J]. Cell, 1984, 37(3):1035-1042.
  • 7[7]DRUKER BJ, TAMURA S, BUCHDUNGER E, et al. Effects of a selective onhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells[J]. Nature, 1996, 2(5):561-566.
  • 8[8]ELISABETH B, JURG Z, METT H, et al. Inhibition of the Abl protein-tyrosine in vitro and in vivo by a 2-phenylaminopyrimidine derivative[J]. Cancer Res, 1996, 56(1):100-104.
  • 9[9]DEININGER MN, GOLDMAN JM, LYDON N, et al. The tyrosine kinase inhibitor CGP 57148 B selectively inhibits the growth of BCR-ABL-positive cells[J]. Blood, 1997, 90(9):3691-3699.
  • 10[10]WANG WL, HEALY ME, SATTLER M, et al. Growth inhibition and modulation of kinase inhibitor STI 571[J]. Oncogene, 2000, 19(31):3521-3528.

同被引文献21

  • 1-[5]See above
  • 2MIETTINEN M, SARLOMO-RIKALA M, LASOTA J. Gastrointestinal stromal tumors: recent advances in understanding of their biology [J]. Hum Pathol, 1999, 30(10): 1213-1220.
  • 3BERMAN J, O'LEARY TJ. Gastrointestinal stromal tumor workshop [J]. Hum Pathol, 2001, 32(6): 578-582.
  • 4de MATTEO RP, LEWIS JJ, LEUNG D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival [J]. Ann Surg, 2000, 231(1): 51-58.
  • 5SAVAGE DG, ANTMAN KH. Imatinib mesylate--a new oral targeted therapy [J]. N Engl J Med, 2002, 346(9): 683-693.
  • 6-[22]See above
  • 7KRYSTAL GW, HONSAWEK S, LITZ J, et al. The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth [J]. Clin Cancer Res, 2000, 6(8): 3319-3326.
  • 8HEINRICH MC, GRIFFITH DJ, DRUKER BJ, et al. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor [J]. Blood,2000, 96(3): 925-932.
  • 9BUCHDUNGER E, CIOFFI CL, LAW N, et al. Abl protein-tyrosine kinase inhibitor ST1571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors [J]. J Pharmacol Exp Ther, 2000, 295(1): 139-145.
  • 10ATTOUB S, RIVAT C, RODRIGUES S, et al. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy [J]. Cancer Res, 2002, 62(17): 4879-4883.

引证文献1

二级引证文献5

中国新药与临床杂志
2002年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部